In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

Becker’s Hospital Review: Larger chunk of hospital drug spending going toward cancer treatments, study finds

An analysis by Lumere, a research and analytics firm that focuses on hospitals, looked at how 26 hospitals from four health systems across the country spent their drug budgets this year. The research found some hospitals are spending a larger chunk of their budgets on new treatments for cancer and migraines, as well as to prevent white cell depletion in chemotherapy patients. read more

Managed Healthcare Executive: Implications of CMS’ New Antibiotic Stewardship Rule

CMS released revised conditions of participation for hospitals and critical access hospitals, which require the development and implementation of antimicrobial stewardship programs (ASPs) to help reduce inappropriate antibiotic use and antimicrobial resistance. Here's what healthcare executives and pharmacy leaders need to know. read more

Crain’s Chicago Business: See who took home this year’s Chicago Innovation Awards

Lumere was selected as a 2019 Chicago Innovation Award winner for its Category Optimization solution. read more

Chicago Inno: Here Are the 2019 Chicago Innovation Award Winners

After reviewing more than 450 nominations, 100 finalists were announced in September and a panel of 14 judges picked this year’s top 25 winners. Among these companies is Lumere for the "Main Category" on behalf of its Category Optimization solution. read more

Lumere’s Category Optimization Solution Named 2019 Chicago Innovation Award Winner

Lumere has been named an 18th annual Chicago Innovation Award winner on behalf of its Category Optimization solution. read more

HIT Consultant: Data: The Foundation For Collaborative Leadership To Deliver High-Value Care

Two recent studies by Lumere and Deloitte found that a significant percentage (70-90%) of physicians believe data on the cost of products would also be valuable in their decision-making process. Unfortunately, only 30% to 40% of those same physicians say they have access to that data or that their organizations were working to provide it. read more

Pharmacy Practice News: Banking Biosimilars Savings: A Call to Action For Health-System Pharmacy Leaders

Encouraging biosimilar adoption is particularly interesting for pharmacy leaders because this decision is within the purview of pharmacy department decision making, and there is a related precedent in the historical adoption and widespread use of generic drugs. Historically, biosimilar products enter the market at 15% to 30% lower cost than the corresponding reference product. read more

Physician’s Practice: Utilizing and implementing data to improve quality of care

One of the greatest and mostly costly areas of variation that physicians control is the selection of the drugs and devices used to treat patients. Lumere recently surveyed nearly 300 physicians to gain insight into what drives their perceptions of clinical variation and the factors that influence their choices of drugs and devices. The results were clear: Physicians crave meaningful data related to cost and variation. read more

Becker’s Hospital Review: How Northwell, Banner Health approach formulary management

Health systems' pharmaceutical spending is expected to rise by up to 6 percent in 2019, making effective formulary management more important than ever. In this article, Northwell Health and Banner Health detail their evidence-based approaches to formulary management. read more